Edwards Lifesciences Investor Relations Material
Latest events
Q1 2025
Edwards Lifesciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Edwards Lifesciences Corporation
Access all reports
Edwards Lifesciences Corporation is an innovative medical-device company, providing products in structural heart disease, and critical care and surgical monitoring that can improve healthcare worldwide. Our comprehensive portfolio includes devices for chronic total occlusions (CTO) repair and treatment of mitral valve disease (MVD). We also design and manufacture mechanical circulatory support devices, including the bioresorbable percutaneous ventricular assist device (BiVAD(TM)) used in advanced heart failure. Edwards Lifesciences Corporation is based in Irvine, California.
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
EW
Country
🇺🇸 United States